Back
Design Therapeutics Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
DSGN
Design Therapeutics
Last Price:
$4.23
Seasonality Move:
-15.97%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight buying pressure.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.52 | Sell |
| 20-day SMA: | 4.75 | Sell |
| 50-day SMA: | 4.68 | Sell |
| 200-day SMA: | 4.98 | Sell |
| 8-day EMA: | 3.62 | Buy |
| 20-day EMA: | 2.23 | Buy |
| 50-day EMA: | 1.09 | Buy |
| 200-day EMA: | 0.3 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.19 | Buy |
| Relative Strength Index (14 RSI): | 40.65 | Sell |
| Chaikin Money Flow: | 10740 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.48 - 5.04) | Sell |
| Bollinger Bands (100): | (4.51 - 6.15) | Sell |
Design Therapeutics Technical Analysis
| Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.21 while DSGN 8-day simple moving average is 4.52, which is a Sell signal.
-
The stock price of DSGN is 4.21 while Design Therapeutics 20-day SMA is 4.75, which makes it a Sell.
-
Design Therapeutics 50-day simple moving average is 4.68 while DSGN share price is 4.21, making it a Sell technically.
-
DSGN stock price is 4.21 and Design Therapeutics 200-day simple moving average is 4.98, creating a Sell signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
29
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a SellThe current Design Therapeutics [DSGN] share price is $4.21. The Score for DSGN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
239M
Price in USD:
4.21
Share Volume:
48.3K
Design Therapeutics 52-Week Range
52-Week High:
7.77
52-Week Low:
3.15
Sell
29
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?The Design Therapeutics stock price is 4.21 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
-
Design Therapeutics share price is 4.21 while DSGN 8-day exponential moving average is 3.62, which is a Buy signal.
-
The stock price of DSGN is 4.21 while Design Therapeutics 20-day EMA is 2.23, which makes it a Buy.
-
Design Therapeutics 50-day exponential moving average is 1.09 while DSGN share price is 4.21, making it a Buy technically.
-
DSGN stock price is 4.21 and Design Therapeutics 200-day simple moving average is 0.30, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.31 per share, and an increase next year of $0.09 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is 1.19, suggesting Design Therapeutics is a Buy
-
Design Therapeutics Relative Strength Index (RSI) is 40.65, which suggest Design Therapeutics is oversold
-
The Bollinger Bands (25) for Design Therapeutics is (4.48 - 5.04), which suggest Design Therapeutics is a Sell
-
The Bollinger Bands (100) for Design Therapeutics is (4.51 - 6.15), which suggest Design Therapeutics is a Sell
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.